From cytopenia to leukemia: The role of Gfi1 and Gfi1b in blood formation

Blood

Volumn 126, Issue 24, 2015, Pages 2561-2569

  Möröy, Tarik ^a,b,c   Vassen, Lothar ^a,d   Wilkes, Brian ^a   Khandanpour, Cyrus ^a,d  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GFI1; TRANSCRIPTION FACTOR GFI1B; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; GFI1 PROTEIN, HUMAN; GFI1 PROTEIN, MOUSE; GFI1B PROTEIN, HUMAN; ONCOPROTEIN; REPRESSOR PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; BLEEDING DISORDER; BONE MARROW CELL; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CHROMATIN STRUCTURE; CYTOPENIA; ENHANCER REGION; ERYTHROCYTE; GENE MUTATION; HEMATOLOGIC DISEASE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HISTONE MODIFICATION; HUMAN; INHERITANCE; LEUKEMIA; LYMPHATIC LEUKEMIA; LYMPHOID CELL; LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RETROVIRIDAE; REVIEW; SEVERE CONGENITAL NEUTROPENIA; T CELL LYMPHOID LEUKEMIA; T CELL LYMPHOMA; THROMBOCYTE; THROMBOCYTOPENIA; ANIMAL; BLOOD CELL; DEFICIENCY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HISTONE CODE; MOLECULAR MODEL; MOUSE; MURINE LEUKEMIA VIRUS; NEUTROPENIA; PHYSIOLOGY; PROTEIN CONFORMATION; REPORTER GENE; TRANSGENIC MOUSE; VIRUS DNA CELL DNA INTERACTION;

ANIMALS; BLOOD CELLS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENES, REPORTER; HEMATOLOGIC DISEASES; HEMATOLOGIC NEOPLASMS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HISTONE CODE; HUMANS; LEUKEMIA VIRUS, MURINE; MICE; MICE, TRANSGENIC; MODELS, MOLECULAR; NEUTROPENIA; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; VIRUS INTEGRATION;

EID: 84951320159     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-06-655043     Document Type: Review

References (88)

1. Gilks CB, Bear SE, Grimes HL, Tsichlis PN. Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol Cell Biol. 1993;13(3): 1759-1768.
2. Zörnig M, Schmidt T, Karsunky H, Grzeschiczek A, Möröy T. Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2. Oncogene. 1996;12(8):1789-1801.
3. Scheijen B, Jonkers J, Acton D, Berns A. Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice. J Virol. 1997;71(1):9-16.
4. Tong B, Grimes HL, Yang TY, et al. The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation. Mol Cell Biol. 1998;18(5):2462-2473.
5. Rödel B, Wagner T, Zörnig M, Niessing J, Möröy T. The human homologue (GFI1B) of the chicken GFI gene maps to chromosome 9q34.13-A locus frequently altered in hematopoietic diseases. Genomics. 1998;54(3):580-582.
6. Schmidt T, Zörnig M, Beneke R, Möröy T. MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene. Nucleic Acids Res. 1996;24(13): 2528-2534.
7. Grimes HL, Chan TO, Zweidler-McKay PA, Tong B, Tsichlis PN. The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal. Mol Cell Biol. 1996; 16(11):6263-6272.
8. Zweidler-Mckay PA, Grimes HL, Flubacher MM, Tsichlis PN. Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor. Mol Cell Biol. 1996; 16(8):4024-4034.
9. Acar M, Jafar-Nejad H, Giagtzoglou N, et al. Senseless physically interacts with proneural proteins and functions as a transcriptional co-activator. Development. 2006;133(10):1979-1989.
10. Duan H, Heckman CA, Boxer LM. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Mol Cell Biol. 2005;25(5): 1608-1619.
11. McGhee L, Bryan J, Elliott L, et al. Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism. J Cell Biochem. 2003;89(5): 1005-1018.
12. Vassen L, Fiolka K, Möröy T. Gfi1b alters histone methylation at target gene promoters and sites of gamma-satellite containing heterochromatin. EMBO J. 2006;25(11):2409-2419.
13. Fiolka K, Hertzano R, Vassen L, et al. Gfi1 and Gfi1b act equivalently in haematopoiesis, but have distinct, non-overlapping functions in inner ear development. EMBO Rep. 2006;7(3): 326-333.
14. Montoya-Durango DE, Velu CS, Kazanjian A, et al. Ajuba functions as a histone deacetylasedependent co-repressor for autoregulation of the growth factor-independent-1 transcription factor. J Biol Chem. 2008;283(46):32056-32065.
15. Hou Z, Peng H, Ayyanathan K, et al. The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression. Mol Cell Biol. 2008; 28(10):3198-3207.
16. Möröy T, Khandanpour C. Growth factor independence 1 (Gfi1) as a regulator of lymphocyte development and activation. Semin Immunol. 2011;23(5):368-378.
17. Phelan JD, Shroyer NF, Cook T, Gebelein B, Grimes HL. Gfi1-cells and circuits: unraveling transcriptional networks of development and disease. Curr Opin Hematol. 2010;17(4):300-307.
18. van der Meer LT, Jansen JH, van der Reijden BA. Gfi1 and Gfi1b: key regulators of hematopoiesis. Leukemia. 2010;24(11):1834-1843.
19. Duan Z, Horwitz M. Gfi-1 takes center stage in hematopoietic stem cells. Trends Mol Med. 2005; 11(2):49-52.
20. Cellot S, Sauvageau G. Gfi-1: another piece in the HSC puzzle. Trends Immunol. 2005;26(2):68-71.
21. Möröy T. The zinc finger transcription factor growth factor independence 1 (Gfi1). Int J Biochem Cell Biol. 2005;37(3):541-546.
22. Kazanjian A, Gross EA, Grimes HL. The growth factor independence-1 transcription factor: new functions and new insights. Crit Rev Oncol Hematol. 2006;59(2):85-97.
23. Duan Z, Horwitz M. Gfi-1 oncoproteins in hematopoiesis. Hematology. 2003;8(5):339-344.
24. Hock H, Orkin SH. Zinc-finger transcription factor Gfi-1: versatile regulator of lymphocytes, neutrophils and hematopoietic stem cells. Curr Opin Hematol. 2006;13(1):1-6.
25. Yücel R, Kosan C, Heyd F, Möröy T. Gfi1:green fluorescent protein knock-in mutant reveals differential expression and autoregulation of the growth factor independence 1 (Gfi1) gene during lymphocyte development. J Biol Chem. 2004;279(39):40906-40917.
26. Vassen L, Okayama T, Möröy T. Gfi1b:green fluorescent protein knock-in mice reveal a dynamic expression pattern of Gfi1b during hematopoiesis that is largely complementary to Gfi1. Blood. 2007;109(6):2356-2364.
27. Zeng H, Yücel R, Kosan C, Klein-Hitpass L, Möröy T. Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J. 2004;23(20):4116-4125.
28. Hock H, Hamblen MJ, Rooke HM, et al. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature. 2004;431(7011):1002-1007.
29. Khandanpour C, Sharif-Askari E, Vassen L, et al. Evidence that growth factor independence 1b regulates dormancy and peripheral blood mobilization of hematopoietic stem cells. Blood. 2010;116(24):5149-5161.
30. Schmidt T, Karsunky H, Gau E, Zevnik B, Elsässer HP, Möröy T. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis. Oncogene. 1998;17(20): 2661-2667.
31. Schmidt T, Karsunky H, Rödel B, Zevnik B, Elsässer HP, Möröy T. Evidence implicating Gfi-1 and Pim-1 in pre-T-cell differentiation steps associated with beta-selection. EMBO J. 1998; 17(18):5349-5359.
32. Vassen L, Beauchemin H, Lemsaddek W, Krongold J, Trudel M, Möröy T. Growth factor independence 1b (gfi1b) is important for the maturation of erythroid cells and the regulation of embryonic globin expression. PLoS One. 2014; 9(5):e96636.
33. Kim W, Klarmann KD, Keller JR. Gfi-1 regulates the erythroid transcription factor network through Id2 repression in murine hematopoietic progenitor cells. Blood. 2014; 124(10):1586-1596.
34. Igwe E, Kosan C, Khandanpour C, Sharif-Askari E, Brüne B, Möröy T. The zinc finger protein Gfi1 is implicated in the regulation of IgG2b production and the expression of Igamma2b germline transcripts. Eur J Immunol. 2008;38(11): 3004-3014.
35. Spooner CJ, Cheng JX, Pujadas E, Laslo P, Singh H. A recurrent network involving the transcription factors PU.1 and Gfi1 orchestrates innate and adaptive immune cell fates. Immunity. 2009;31(4):576-586.
36. Spooner CJ, Lesch J, Yan D, et al. Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1. Nat Immunol. 2013;14(12): 1229-1236.
37. Zhu J, Jankovic D, Grinberg A, Guo L, Paul WE. Gfi-1 plays an important role in IL-2-mediated Th2 cell expansion. Proc Natl Acad Sci USA. 2006; 103(48):18214-18219.
38. Rathinam C, Geffers R, Yücel R, et al. The transcriptional repressor Gfi1 controls STAT3-dependent dendritic cell development and function. Immunity. 2005;22(6): 717-728.
39. Chow KT, Schulz D, McWhirter SM, Schlissel MS. Gfi1 and gfi1b repress rag transcription in plasmacytoid dendritic cells in vitro. PLoS One. 2013;8(9):e75891.
40. Khandanpour C, Krongold J, Schütte J, et al. The human GFI136N variant induces epigenetic changes at the Hoxa9 locus and accelerates K-RAS driven myeloproliferative disorder in mice. Blood. 2012;120(19):4006-4017.
41. Horman SR, Velu CS, Chaubey A, et al. Gfi1 integrates progenitor versus granulocytic transcriptional programming. Blood. 2009; 113(22):5466-5475.
42. Dahl R, Iyer SR, Owens KS, Cuylear DD, Simon MC. The transcriptional repressor GFI-1 antagonizes PU.1 activity through proteinprotein interaction. J Biol Chem. 2007;282(9): 6473-6483.
43. Wilson NK, Foster SD, Wang X, et al. Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell. 2010;7(4):532-544.
44. Jegalian AG, Wu H. Regulation of Socs gene expression by the proto-oncoprotein GFI-1B: two routes for STAT5 target gene induction by erythropoietin. J Biol Chem. 2002;277(3): 2345-2352.
45. Doan LL, Kitay MK, Yu Q, et al. Growth factor independence-1B expression leads to defects in T cell activation, IL-7 receptor alpha expression, and T cell lineage commitment. J Immunol. 2003; 170(5):2356-2366.
46. Xu W, Kee BL. Growth factor independent 1B (Gfi1b) is an E2A target gene that modulates Gata3 in T-cell lymphomas. Blood. 2007;109(10): 4406-4414.
47. Kuo YY, Chang ZF. GATA-1 and Gfi-1B interplay to regulate Bcl-xL transcription. Mol Cell Biol. 2007;27(12):4261-4272.
48. Chowdhury AH, Ramroop JR, Upadhyay G, Sengupta A, Andrzejczyk A, Saleque S. Differential transcriptional regulation of meis1 by Gfi1b and its co-factors LSD1 and CoREST. PLoS One. 2013;8(1):e53666.
49. Moignard V, Macaulay IC, Swiers G, et al. Characterization of transcriptional networks in blood stem and progenitor cells using highthroughput single-cell gene expression analysis. Nat Cell Biol. 2013;15(4):363-372.
50. Schulz D, Vassen L, Chow KT, et al. Gfi1b negatively regulates Rag expression directly and via the repression of FoxO1. J Exp Med. 2012; 209(1):187-199.
51. Northcott PA, Lee C, Zichner T, et al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature. 2014;511(7510): 428-434.
52. Khandanpour C, Phelan JD, Vassen L, et al. Growth factor independence 1 antagonizes a p53-induced DNA damage response pathway in lymphoblastic leukemia. Cancer Cell. 2013;23(2): 200-214.
53. Phelan JD, Saba I, Zeng H, et al. Growth factor independent-1 maintains Notch1- dependent transcriptional programming of lymphoid precursors. PLoS Genet. 2013;9(9): e1003713.
54. Vassen L, Dührsen U, Kosan C, Zeng H, Möröy T. Growth factor independence 1 (Gfi1) regulates cell-fate decision of a bipotential granulocytic-monocytic precursor defined by expression of Gfi1 and CD48. Am J Blood Res. 2012;2(4):228-242.
55. Foudi A, Kramer DJ, Qin J, et al. Distinct, strict requirements for Gfi-1b in adult bone marrow red cell and platelet generation. J Exp Med. 2014; 211(5):909-927.
56. Khandanpour C, Kosan C, Gaudreau MC, et al. Growth factor independence 1 protects hematopoietic stem cells against apoptosis but also prevents the development of a myeloproliferative-like disease. Stem Cells. 2011; 29(2):376-385.
57. Laslo P, Pongubala JM, Lancki DW, Singh H. Gene regulatory networks directing myeloid and lymphoid cell fates within the immune system. Semin Immunol. 2008;20(4): 228-235.
58. Laslo P, Spooner CJ, Warmflash A, et al. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell. 2006;126(4):755-766.
59. Person RE, Li FQ, Duan Z, et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet. 2003; 34(3):308-312.
60. Karsunky H, Zeng H, Schmidt T, et al. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat Genet. 2002;30(3):295-300.
61. Hock H, Hamblen MJ, Rooke HM, et al. Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. Immunity. 2003; 18(1):109-120.
62. Jin J, Zeng H, Schmid KW, Toetsch M, Uhlig S, Möröy T. The zinc finger protein Gfi1 acts upstream of TNF to attenuate endotoxin-mediated inflammatory responses in the lung. Eur J Immunol. 2006;36(2):421-430.
63. Grassmé H, Jin J, Wilker B, et al. Regulation of pulmonary Pseudomonas aeruginosa infection by the transcriptional repressor Gfi1. Cell Microbiol. 2006;8(7):1096-1105.
64. Krumsiek J, Marr C, Schroeder T, Theis FJ. Hierarchical differentiation of myeloid progenitors is encoded in the transcription factor network. PLoS One. 2011;6(8):e22649.
65. Dias S, Månsson R, Gurbuxani S, Sigvardsson M, Kee BL. E2A proteins promote development of lymphoid-primed multipotent progenitors. Immunity. 2008;29(2):217-227.
66. Yücel R, Karsunky H, Klein-Hitpass L, Möröy T. The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit1 T cell progenitors and CD4/CD8 lineage decision in the thymus. J Exp Med. 2003; 197(7):831-844.
67. Saleque S, Cameron S, Orkin SH. The zincfinger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages. Genes Dev. 2002; 16(3):301-306.
68. Vassen L, Fiolka K, Mahlmann S, Möröy T. Direct transcriptional repression of the genes encoding the zinc-finger proteins Gfi1b and Gfi1 by Gfi1b. Nucleic Acids Res. 2005;33(3): 987-998.
69. Li J, Kuter DJ. The end is just the beginning: megakaryocyte apoptosis and platelet release. Int J Hematol. 2001;74(4):365-374.
70. Mikkers H, Allen J, Knipscheer P, et al. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer [published corrections appears in Nat Genet. 2002;32(2):331 and Nat Genet. 2002; 32(3):459]. Nat Genet. 2002;32(1):153-159.
71. Sanda T, Li X, Gutierrez A, et al. Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia. Blood. 2010; 115(9):1735-1745.
72. Chiaretti S, Li X, Gentleman R, et al. Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. Blood. 2004;103(7): 2771-2778.
73. Huser CA, Gilroy KL, de Ridder J, et al. Insertional mutagenesis and deep profiling reveals gene hierarchies and a Myc/p53-dependent bottleneck in lymphomagenesis. PLoS Genet. 2014;10(2): e1004167.
74. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100(7): 2292-2302.
75. Head DR. Revised classification of acute myeloid leukemia. Leukemia. 1996;10(11):1826-1831.
76. Leith CP, Kopecky KJ, Godwin J, et al. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood. 1997; 89(9):3323-3329.
77. Khandanpour C, Thiede C, Valk PJ, et al. A variant allele of growth factor independence 1 (GFI1) is associated with acute myeloid leukemia. Blood. 2010;115(12):2462-2472.
78. Zarebski A, Velu CS, Baktula AM, et al. Mutations in growth factor independent-1 associated with human neutropenia block murine granulopoiesis through colony stimulating factor-1. Immunity. 2008;28(3):370-380.
79. de la Luz Sierra M, Sakakibara S, Gasperini P, et al. The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1. Blood. 2010; 115(19):3970-3979.
80. Welte K, Zeidler C, Dale DC. Severe congenital neutropenia. Semin Hematol. 2006;43(3): 189-195.
81. Xia J, Bolyard AA, Rodger E, et al. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia. Br J Haematol. 2009;147(4): 535-542.
82. Lebel A, Yacobovich J, Krasnov T, et al. Genetic analysis and clinical picture of severe congenital neutropenia in Israel. Pediatr Blood Cancer. 2015; 62(1):103-108.
83. Alizadeh Z, Fazlollahi MR, Houshmand M, et al. Different pattern of gene mutations in Iranian patients with severe congenital neutropenia (including 2 new mutations). Iran J Allergy Asthma Immunol. 2013;12(1):86-92.
84. Boztug K, Klein C. Genetics and pathophysiology of severe congenital neutropenia syndromes unrelated to neutrophil elastase. Hematol Oncol Clin North Am. 2013;27(1):43-60, vii.
85. Klein C. Genetic defects in severe congenital neutropenia: emerging insights into life and death of human neutrophil granulocytes. Annu Rev Immunol. 2011;29: 399-413.
86. Stevenson WS, Morel-Kopp MC, Chen Q, et al. GFI1B mutation causes a bleeding disorder with abnormal platelet function. J Thromb Haemost. 2013;11(11):2039-2047.
87. Monteferrario D, Bolar NA, Marneth AE, et al. A dominant-negative GFI1B mutation in the gray platelet syndrome. N Engl J Med. 2014;370(3): 245-253.
88. Chen L, Kostadima M, Martens JH, et al; BRIDGE Consortium. Transcriptional diversity during lineage commitment of human blood progenitors. Science. 2014;345(6204):1251033.